Week 8: Neurological/Neurogenerative Disorders Flashcards

1
Q

Aging Changes and Their Effects on the Nervous System Effects: The Brain

A
  • Breakdown of nerves can affect the senses
  • Blood flow to brain may decrease by 20%
  • Slowing of though, memory and thinking is a normal part of aging
  • Dementia and severe memory loss are NOT a normal part of aging.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Aging Changes and Their Effects on the Nervous System: Vertebra

A

The disks between the vertebra become hard and brittle, as well as part of the Vertebra may over grow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aging Changes and Their Effects on the Nervous System: Nerves

A
  • Peripheral Nerves may conduct impulses more slowly -> decreased sensation and often some clumsiness
  • PNS response to injury is reduced.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Neurogenerative Disorders: Diagnosis

A
  • Evaluation done when changes are noted in comparison to a prior state of cognition, especially memory or physical stability such as balance or tremors.
  • Diagnostic process begins with the assessment of potentially all reversible causes for changes such as delirium, infection, vitamin deficiencies or endocrine disturbances.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signs and Symptoms of Neurocognitive Disorders

A
  • Decline from prior state with slow onset
  • Decline in memory and learning
  • Potential declines in attention, executive function, language, perceptual motor, social cognition
  • Fluctuating cognition
  • Recurrent hallucinations
  • Movement disturbances
  • Possible sleep disturbances
  • No evidence of reversible causes for symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Parkinson’s Disease

A

-In late stages, many develop NCDs, referred to as PD dementia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Parkinson’s Disease: Diagnosis

A
  • Diagnosis can be made with reasonable certainty considering the absence or presence of classic signs and symptoms
  • Confirmed by a “challenge test” when symptoms improve dramatically after the administration of levodopa.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Characteristics of other movement disorders include

A
  • Early falls
  • Poor response to levodopa
  • Symmetry of motor symptoms
  • Lack of tremor
  • Early autonomic dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Parkinson’s Disease: Etiology

A
  • Deficiency of the neurotransmitter dopamine, a reduction in dopamine receptors and the accumulation of LB, especially in the basal ganglia.
  • Epigenetic factors influence development
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Severity of Parkinson’s Disease is associated with

A

Degree of neuron loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Parkinson’s Disease: By the time a person becomes symptomatic,

A

70-90% of dopamine producing cells are lost.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the four core signs of Parkinson’s Disease?

A
  • Resting Tremor
  • Muscular Rigidity
  • Bradykinesia
  • Asymmetric onset

-Muscle rigidity is another symptom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is often the first sign of Parkinson’s Disease?

A

Resting Tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Muscle Rigidity and bradykinesia may worsen in PD, affecting the

A

Striated muscles in the extremities, trunk and ocular areas, including muscles of chewing, swallowing and speaking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Is there a cure for Parkinson’s Disease?

A

No cure for PD, but when symptoms interfere with function, pharmacological interventions are initiated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What medications are used to treat parkinson’s disease?

A
  • First line medication: Levodopa

- Other drugs: Carbidopa and dopamine agonists.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When medications don’t provide relief from disabling symptoms of PD, patients may elect to have surgical intervention such as

A

Deep brain simulation or ablation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Nonpharmacological treatment for PD includes

A

Gait training and muscle strengthening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Alzheimer’s Disease: Etiology

A
  • Familial AD, caused by a single gene mutation on one of three chromosomes: 21, 14 or 1.
  • Most AD in persons >60 is likely due to a number of factors
  • APOE gene type e4 is found in 40% of late onset AD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Persons with NCD d/t AD also have increased number of

A

B-amyloid proteins outside the neuron and accumulation of tau proteins inside the neuron.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Symptoms of Alzheimers Disease include

A
  • Initial symptom is memory loss, specifically the ability to remember new information
  • Additional S&S develop overtime
  • Functional decline correlates to cognitive decline.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

5 A’s To Alzheimer’s Diagnosis include

A
  • Anomia: inability to remember names
  • Apraxia: missuse of objects because of failure to identify them
  • Agnosia: inability to recognize familiar objects, tastes, sounds and other sensations
  • Amnesia
  • Aphasia: inability to express oneself through speech
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diagnosis of NCD due to Alzheimer’s Disease requires

A
  • a decline from previous level of functioning.
  • the onset was insidious.
  • there has been a gradual progression in cognitive abilities.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

NCD disorders are now characterized as

A

Possible or probably and major or minor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Pharmacological therapy for Alzheimer’s Disease is aimed at

A

Slowing cognitive decline

26
Q

Medications used to treat Alzheimer’s Disease include

A
  • Cholinesterase inhibitors: donepezil, galantamine, rivastigmine
  • Regulation of the activity of glutamate: memantine HCl
27
Q

Neurocognitive Dementia with Levy Bodies (LB)

A

-Cognitive changes always precede movement disorders

28
Q

Signs and Symptoms of Neurocognitive Dementia with LB

A
  • Severe loss of thinking, especially problem solving, use of language and numerical concepts.
  • Fluctuating attention and alertness
  • Hallucinations which may lead to delusions and paranoia
  • Disordered sleep
  • Mood problems: depression, apathy, anxiety and agitation
  • Autonomic S&S
29
Q

Neurocognitive Dementia with LB: Etiology

A
  • Normal healthy brains have alpha-synuclein proteins that help neurons communicate with each other at their synapse, but in LB abnormal spherical protein aggregates are found within neurons.
  • Alpha-synuclein is highly expressed with these bodies, which displace other cellular structures and may contribute to cell death.
  • Progression of the disease leads to significant deficits in neurotransmitter production along the cholinergic and dopaminergic pathways.
30
Q

Neurocognitive Dementia with LB: Diagnosis

A
  • According to the new DSM-5 diagnostic criteria, the person identified as one with NCD due to LB must first meet all of the initial mild or moderate criteria for other NCDs and then be classified as “possible” or “probable”.
  • Based on the presentation of the core features
31
Q

Pharmacological Treatment for Neurocognitive Dementia with LB

A
  • Cholinesterase inhibitors
  • Benzodiazepines
  • Clonazepam
32
Q

What type of medication should never be used in people with NCD due to LB?

A

Typical antipsychotics (i.e. Haldol) can never be used in persons with NCD due to LB due to a very high rate of irreversible side effects and possible death.

33
Q

Complications of Neurocognitive Dementia with LB include

A
  • Pressure Ulcers
  • Pneumonia
  • Dysphagia
  • Aspiration
  • Under nutrition and weight loss
  • Behavioral Disturbances
34
Q

Treatment for these disorders focuses on:

A
  • relieving symptoms with medication.
  • increasing functional ability.
  • preventing excess disability.
  • decreasing risk for injury.
35
Q

Key factors in care of the gerontological population include

A
  • appropriate use of nonpharmacological and pharmacological interventions.
  • prompt treatment of reversible conditions.
  • coordination between all care providers.
36
Q

What are the three D’s of cognitive impairment?

A
  • Depression
  • Delirium
  • Dementia (Mild and major NCDs)
37
Q

Delirium is characterized by

A

An acute or subacute onset with symptoms over a short period of time.

38
Q

Major and mild NCD: Characteristics

A
  • Gradual onset

- Slow steady pattern of decline without alterations in consciousness.

39
Q

Predisposing Factors for Neurocognitive Disorders

A
  • Underlying cognitive impairment
  • Functional impairment
  • Depression
  • Acute illness
  • Sensory impairment
40
Q

Precipitating Factors for Neurocognitive Disorders

A
  • Medications
  • Procedures
  • Restraints
  • Iatrogenic events
  • Sleep deprivation
  • Bladder catheter
  • Pain
  • Environmental factors
41
Q

Older patients with NCDs are

A

3-5 times more likely to develop delirium

42
Q

Delirium superimposed on NCDs can

A

Accelerate the trajectory of cognitive decline and is associated with high mortality

43
Q

Recognition of Delirium

A
  • Is a medical emergency and one of the most significant geriatric syndromes.
  • Failure to recognize delirium, identify underlying causes and implement timely interventions contribute to negative sequelae.
44
Q

Risk factors for delirium

A

Box 29-1

45
Q

Drugs that cause or contribute to Delirium include

A

46
Q

Clinical Subtypes of delirium include

A
  • Hyperactive
  • Hypoactive
  • Mixed
47
Q

Recognizing delirium

A

Box 29-4

48
Q

Consequences of Delirium

A
  • Terrifying experience for the individual and his or her family and significant others
  • Associated with increased length of stay and hospital readmissions, increased services after discharge, increased morbidity, mortality, and institutionalization, independent of age, co-existing illness, or illness severity.
49
Q

Assessment of Delirium

A
  • Begins with a good history and identification of key diagnostic features.
  • MMSE-2 alone is not adequate for diagnosing delirium.
  • Confusion Assessment Method (CAM) (Box 29-8, Touhy & Jett).
  • NEECHAM Confusion Scale.
50
Q

Nonpharmacological Interventions for Delirium include

A
  • Person-centered approach to delirium
  • Hospital Elder Life Program
  • Interventions to prevent delirium
51
Q

Care of Individuals with Mild and Major NCD: Overriding Goals

A

The overriding goals in caring for older adults with dementia are to maintain stability and function, compensate for the losses associated with the disease, and create a therapeutic milieu that nurtures the personhood of the individual and maintains quality of life.

52
Q

How often should assessment for neurological disorders be done?

A

Occurs every 6 months to 1 year after diagnosis or at any time there is a change in behavior or increase in the rate of decline.

53
Q

Areas of concern for caregivers of persons with mild NCD and EOD center less on personal care and more on

A

Communication, behavior and relationships

54
Q

Person-centered care in patients with Neurocognitive disorders

A

Irreversible NCDs have no cure, and although medications offer hope for improved function, the most important treatment for the disease is competent and compassionate person-centered care.

55
Q

Communication in older adults with Neurocognitive disorders

A
  • Communication with older adults experiencing NCDs requires special skills and patience.
  • Even in later stages of NCD, the person may understand more than you realize and still needs opportunities for interaction and caring communication, both verbal and nonverbal.
  • To effectively communicate with a person experiencing NCD, it is essential to believe the person is trying to communicate something important.
  • The person with NCD cannot change his or her communication; we must change ours
56
Q

Progressively Lowered Stress Threshold Model

A

57
Q

Need-Driven Dementia-Compromised Behavior Model

A

..

58
Q

Bathing of persons with dementia

A

Can be perceived as a personal attack by persons with dementia, who may respond by striking out.

59
Q

Wandering associated with dementia

A
  • One of the most difficult management problems encountered in the home and institutional settings.
  • Defined as “a syndrome of dementia-related locomotion behavior having frequent, repetitive, temporarily disordered and/or spatially disoriented nature that is manifested in lapping, random, and/or pacing patterns, some of which is associated with eloping …”
60
Q

Assessments for Wandering Associated with Dementia

A
  • Careful assessment of physical problems that may trigger wandering, such as acute illness, exacerbations of chronic illness, fatigue, medication effects, and constipation.
  • Interventions for wandering (Box 29-27, Touhy & Jett).
  • Wandering behavior may also result in people with dementia going outside and getting lost.
  • Recommendations to avoid individuals with dementia getting lost (Box 29-28, Touhy & Jett).
61
Q

Nutrition in Older Adults with Dementia

A
  • Older adults with dementia are particularly at risk for weight loss and inadequate nutrition.
  • The Mini Nutritional Analysis is an easy tool to identify those at risk.
  • One of the best strategies for managing poor intake is establishing a routine so the older person does not have to remember time and places for eating.
  • Improving intake for individuals with dementia (Box 29-29, Touhy & Jett).